H. B. Fuller (NYSE:FUL) Shares Gap Down – Here’s What Happened

H. B. Fuller Company (NYSE:FUL) gapped down before the market opened on Thursday . The stock had previously closed at $64.60, but opened at $61.42. H. B. Fuller shares last traded at $59.2640, with a volume of 119,290 shares traded.

Trending Headlines about H. B. Fuller

Here are the key news stories impacting H. B. Fuller this week:

• Positive Sentiment: H. B. Fuller reported second-quarter EPS of $1.41, beating Wall Street estimates, and revenue of $950.3 million, also ahead of expectations, with sales up 5.8% year over year. The company also raised FY2026 guidance to $4.60-$4.90 EPS, signaling management confidence in the business. H.B. Fuller Reports Second Quarter 2026 Results
• Positive Sentiment: Operating trends were solid, with organic revenue up 2.6% and adjusted gross margin improving 200 basis points, helped by pricing and restructuring savings. H.B. Fuller Reports Second Quarter 2026 Results
• Negative Sentiment: Investor concern is centered on the announced Advanced Medical Solutions acquisition, which some shareholders have criticized as reckless and not aligned with their opposition, creating uncertainty around capital allocation and deal execution. Ancora Condemns H.B. Fuller’s Decision to Ignore Shareholder Opposition and Proceed with the Reckless Acquisition of Advanced Medical Solutions
• Negative Sentiment: The AMS transaction is a sizable cash purchase valued at roughly £715 million, or about $942 million including debt, which may raise leverage and integration-risk concerns even though it expands H. B. Fuller’s medical portfolio. H.B. Fuller to buy UK’s Advanced Medical Solutions for $942 million

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on FUL shares. UBS Group increased their price target on shares of H. B. Fuller from $63.00 to $71.00 and gave the company a “neutral” rating in a report on Wednesday, June 17th. JPMorgan Chase & Co. upgraded H. B. Fuller from an “underweight” rating to a “neutral” rating and set a $58.00 target price on the stock in a research report on Wednesday, May 27th. Citigroup upped their target price on H. B. Fuller from $67.00 to $70.00 and gave the company a “buy” rating in a report on Monday, March 30th. Royal Bank Of Canada set a $58.00 price target on H. B. Fuller in a research note on Wednesday, May 27th. Finally, Wall Street Zen upgraded shares of H. B. Fuller from a “hold” rating to a “buy” rating in a research report on Sunday, March 29th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, H. B. Fuller presently has a consensus rating of “Moderate Buy” and an average target price of $66.40.

H. B. Fuller Price Performance

The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.15 and a current ratio of 1.92. The company has a 50-day moving average of $61.62 and a 200-day moving average of $61.26. The stock has a market capitalization of $3.26 billion, a price-to-earnings ratio of 19.72, a P/E/G ratio of 0.83 and a beta of 0.96.

H. B. Fuller (NYSE:FUL) last announced its earnings results on Wednesday, June 24th. The specialty chemicals company reported $1.41 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.04. The firm had revenue of $950.27 million for the quarter, compared to analysts’ expectations of $924.83 million. H. B. Fuller had a return on equity of 11.84% and a net margin of 4.62%.H. B. Fuller’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.18 EPS. H. B. Fuller has set its FY 2026 guidance at 4.600-4.900 EPS. As a group, equities research analysts expect that H. B. Fuller Company will post 4.78 earnings per share for the current fiscal year.

H. B. Fuller Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, May 14th. Investors of record on Thursday, April 30th were paid a $0.245 dividend. This represents a $0.98 annualized dividend and a yield of 1.6%. The ex-dividend date of this dividend was Thursday, April 30th. This is a positive change from H. B. Fuller’s previous quarterly dividend of $0.23. H. B. Fuller’s dividend payout ratio is presently 32.34%.

Insider Activity

In other news, CEO Celeste Beeks Mastin purchased 5,170 shares of the firm’s stock in a transaction on Tuesday, April 7th. The shares were bought at an average cost of $57.08 per share, with a total value of $295,103.60. Following the purchase, the chief executive officer directly owned 8,670 shares of the company’s stock, valued at approximately $494,883.60. This trade represents a 147.71% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.83% of the stock is owned by corporate insiders.

Institutional Trading of H. B. Fuller

Hedge funds have recently bought and sold shares of the company. Allworth Financial LP boosted its holdings in shares of H. B. Fuller by 50.1% during the fourth quarter. Allworth Financial LP now owns 578 shares of the specialty chemicals company’s stock worth $34,000 after purchasing an additional 193 shares during the last quarter. Hantz Financial Services Inc. increased its stake in H. B. Fuller by 432.9% in the fourth quarter. Hantz Financial Services Inc. now owns 778 shares of the specialty chemicals company’s stock valued at $46,000 after purchasing an additional 632 shares during the last quarter. Aster Capital Management DIFC Ltd acquired a new position in H. B. Fuller in the fourth quarter valued at $46,000. Torren Management LLC purchased a new position in H. B. Fuller during the fourth quarter worth about $52,000. Finally, Brown Brothers Harriman & Co. purchased a new position in H. B. Fuller during the third quarter worth about $56,000. Institutional investors and hedge funds own 95.93% of the company’s stock.

About H. B. Fuller

H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.

Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.